Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study (Q33391428)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

title

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

main subject

eliglustat tartrate

1 reference

stated in

ChEBI release 2020-05-28

ChEBI ID

83353

eliglustat

1 reference

stated in

ChEBI release 2020-05-28

ChEBI ID

82752

tartrate

1 reference

based on heuristic

inferred from title

Gaucher's disease

1 reference

based on heuristic

inferred from title

author

Gregory M Pastores

series ordinal

8

object named as

Gregory M Pastores

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

author name string

Elena Lukina

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Nora Watman

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Elsa Avila Arreguin

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Marta Dragosky

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Marcelo Iastrebner

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Hanna Rosenbaum

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Mici Phillips

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Ravi S Kamath

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Daniel I Rosenthal

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Mathilde Kaper

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Tejdip Singh

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

Ana Cristina Puga

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

M Judith Peterschmitt

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

language of work or name

English

0 references

publication date

16 August 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

published in

Blood

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

volume

116

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

issue

20

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

page(s)

4095-4098

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

cites work

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993616

retrieved

21 June 2018

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993616

retrieved

21 June 2018

Evidence-based recommendations for monitoring bone disease and the response to enzyme replacement therapy in Gaucher patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993616

retrieved

21 June 2018

Therapeutic goals in the treatment of Gaucher disease.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993616

retrieved

21 June 2018

Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993616

retrieved

21 June 2018

The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2993616

retrieved

31 October 2018

Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20713962

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of Gaucher disease using magnetic resonance imaging

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20713962

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20713962

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20713962

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20713962

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety, Tolerability, and Pharmacokinetics of Eliglustat Tartrate (Genz-112638) After Single Doses, Multiple Doses, and Food in Healthy Volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20713962

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1182/BLOOD-2010-06-293902

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

PMC publication ID

2993616

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

PubMed publication ID

20713962

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20713962

retrieved

26 July 2017

ResearchGate publication ID

45660276

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33391428&oldid=2246680831"